139 related articles for article (PubMed ID: 33790390)
1. A practical method to screen and identify functioning biomarkers in nasopharyngeal carcinoma.
Liu C; Guo P; Zhou L; Wang Y; Tian S; Ding Y; Wu J; Zhu J; Wang Y
Sci Rep; 2021 Mar; 11(1):7294. PubMed ID: 33790390
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma.
Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Li W; Fu Z
World J Surg Oncol; 2019 Apr; 17(1):60. PubMed ID: 30935420
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation biomarkers for nasopharyngeal carcinoma.
Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
[TBL] [Abstract][Full Text] [Related]
4. Differentially Expressed Genes in Nasopharyngeal Carcinoma Tissues and Their Correlation with Recurrence and Metastasis of Nasopharyngeal Carcinoma.
Yue H; Zhu H; Luo D; Du Q; Xie Y; Huang S; Liu W
Comput Math Methods Med; 2022; 2022():1941412. PubMed ID: 35509856
[TBL] [Abstract][Full Text] [Related]
5. Identification of Potential Therapeutic Gene Markers in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
Xue K; Cao J; Wang Y; Zhao X; Yu D; Jin C; Xu C
Clin Transl Sci; 2020 Mar; 13(2):265-274. PubMed ID: 31863646
[TBL] [Abstract][Full Text] [Related]
6. Key genes affecting the progression of nasopharyngeal carcinoma identified by RNA-sequencing and bioinformatic analysis.
Wang Y; Li M; Guo Y; Huang H; Dong X; Sun Y; Liu J
Aging (Albany NY); 2021 Sep; 13(18):22176-22187. PubMed ID: 34544905
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of multiple gene expression profiling datasets revealed novel gene signatures and molecular markers in nasopharyngeal carcinoma.
Huang C; Tang H; Zhang W; She X; Liao Q; Li X; Wu M; Li G
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):166-75. PubMed ID: 22068284
[TBL] [Abstract][Full Text] [Related]
8. Identification of candidate genes of nasopharyngeal carcinoma by bioinformatical analysis.
Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Fu Z
Arch Oral Biol; 2019 Oct; 106():104478. PubMed ID: 31319350
[TBL] [Abstract][Full Text] [Related]
9. Identifying key genes and small molecule compounds for nasopharyngeal carcinoma by various bioinformatic analysis.
Fang L; Shi L; Wang W; Chen Q; Rao X
Medicine (Baltimore); 2021 Sep; 100(37):e27257. PubMed ID: 34664875
[TBL] [Abstract][Full Text] [Related]
10. Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling.
Shi W; Bastianutto C; Li A; Perez-Ordonez B; Ng R; Chow KY; Zhang W; Jurisica I; Lo KW; Bayley A; Kim J; O'Sullivan B; Siu L; Chen E; Liu FF
Int J Cancer; 2006 Nov; 119(10):2467-75. PubMed ID: 16858677
[TBL] [Abstract][Full Text] [Related]
11. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
Liu M; Zhu K; Qian X; Li W
Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
[TBL] [Abstract][Full Text] [Related]
12. Novel biomarkers of nasopharyngeal carcinoma metastasis risk identified by reverse phase protein array based tumor profiling with consideration of plasma Epstein-Barr virus DNA load.
Xu T; Su B; Huang P; Wei W; Deng Y; Sehgal V; Wang D; Jiang J; Zhang G; Li A; Yang H; Claret FX
Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 27883284
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics analysis identifies potential biomarkers involved in the metastasis of locoregionally advanced nasopharyngeal carcinoma.
Hu R; Xu X; Mo L; Chen M; Liu Y
Medicine (Baltimore); 2022 Sep; 101(35):e30126. PubMed ID: 36107539
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of the nasopharyngeal carcinoma primary tumor‑associated gene interaction network.
An F; Zhang Z; Xia M
Mol Med Rep; 2015 Oct; 12(4):4975-80. PubMed ID: 26238040
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel microRNA profile including miR-106b, miR-17, miR-20b, miR-18a and miR-93 in the metastasis of nasopharyngeal carcinoma.
Zhou W; Chang A; Zhao H; Ye H; Li D; Zhuo X
Cancer Biomark; 2020; 27(4):533-539. PubMed ID: 32083569
[TBL] [Abstract][Full Text] [Related]
16. MYC and hsa‑miRNA‑423‑5p as biomarkers in nasopharyngeal carcinoma revealed by miRNA‑mRNA‑pathway network integrated analysis.
Tian H; Chen S; Zhang C; Li M; Zheng H
Mol Med Rep; 2017 Aug; 16(2):1039-1046. PubMed ID: 28586063
[TBL] [Abstract][Full Text] [Related]
17. Identification of prognostic biomarkers for response to radiotherapy by DNA microarray in nasopharyngeal carcinoma patients.
Yang S; Chen J; Guo Y; Lin H; Zhang Z; Feng G; Hao Y; Cheng J; Liang P; Chen K; Wu H; Li Y
Int J Oncol; 2012 May; 40(5):1590-600. PubMed ID: 22267178
[TBL] [Abstract][Full Text] [Related]
18. EPHB2 as a recurrence-related gene and a prognostic indicator in nasopharyngeal carcinoma: A bioinformatics screening and immunohistochemistry verification.
Ling J; Chang A; Zhao H; Ye H; Zhuo X
Histol Histopathol; 2022 Sep; 37(9):889-897. PubMed ID: 35441696
[TBL] [Abstract][Full Text] [Related]
19. Integrated miRNA-mRNA analysis of Epstein-Barr virus-positive nasopharyngeal carcinoma.
Zhu LH; Miao XT; Wang NY
Genet Mol Res; 2015 Jun; 14(2):6028-36. PubMed ID: 26125802
[TBL] [Abstract][Full Text] [Related]
20. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
Hu W; Xiao L; Cao C; Hua S; Wu D
Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
